Literature DB >> 8559041

Persistent Yersinia enterocolitica infection in three rat strains.

J H Curfs1, J F Meis, H A Van der Lee, J A Mulder, W A Kraak, J A Hoogkamp-Korstanje.   

Abstract

Yersinia enterocolitica may persist for prolonged periods of time in humans sometimes resulting in the development of reactive arthritis. To elucidate factors predisposing for persistence we developed animal models. In Lewis and Fischer rats, viable bacteria could be demonstrated for prolonged time and abscesses could be found in the liver, spleen and lungs. Splenic abscesses were observed for more than 20 weeks. Yersinia enterocolitica persisted in Lewis and Fischer rats, but only Lewis rats developed reactive arthritis. In Brown Norway rats abscesses developed early during infection but in contrast to the other strains disappeared after 3 weeks. Culture of homogenized abscess-containing tissue of all three rat strains yielded Yersiniae. Immunofluorescence studies of the abscesses showed diffuse staining inside the abscesses only, indicating the presence of Yersinia enterocolitica antigen. Brown Norway rats, in contrast to Lewis and Fischer rats, developed a different serological reaction pattern against Yersinia enterocolitica antigens and this correlated with the disappearance of the abscesses.

Entities:  

Mesh:

Year:  1995        PMID: 8559041     DOI: 10.1006/mpat.1995.0045

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  2 in total

1.  In situ localisation of Yersinia enterocolitica by catalysed reported deposition signal amplification.

Authors:  P T Odinot; J F Meis; J A Hoogkamp-Korstanje; W J Melchers
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

2.  No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study.

Authors:  G Effraimidis; J G P Tijssen; T G A Strieder; W M Wiersinga
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.